Court Rules In Favor Of Mylan In Patent Infringement Litigation Against Sunovion

(RTTNews) - Mylan Inc. (MYL) announced that the U.S. District Court for the Southern District of New York has issued a Final Judgment and Order following a ruling by the Court of Appeals for the Federal Circuit in favor of Mylan Specialty L.P., f/k/a Dey Pharma, L.P.

The Order states that five of Mylan's patents related to its Perforomist Inhalation Solution are valid and enforceable. Further, the Order states that Sunovion's Brovana product infringes each of those patents.

Mylan previously announced a settlement agreement with Sunovion resolving the litigation relating to Sunovion's Brovana product. In May 2012, the U.S. District Court for the Southern District of New York issued a Final Judgment and Order stating that Sunovion has acknowledged that two Mylan patents related to its Perforomist Inhalation Solution are valid, enforceable and infringed by Sunovion's Brovana product.

As a result of the two Court Orders, all seven Mylan patents relating to Perforomist have been upheld as valid and enforceable and infringed by Sunovion's Brovana product.